⌘K

Login Start Free

Home/Filings/4/0001179110-11-006775

4//SEC Filing

Thomas Helmut 4

Accession 0001179110-11-006775

CIK 0001274644other

View on SEC.gov Company Profile

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 6:18 PM ET

Size

5.3 KB

Accession

0001179110-11-006775

Insider Transaction Report

Form 4

Period: 2011-04-19

TRANZYME INCTZYM

Senior VP, R&D

Transactions

Award
Stock Option (right to buy)
2011-04-19+78,641→ 78,641 total
Exercise: $4.00Exp: 2021-04-19→ Common Stock (78,641 underlying)

Footnotes (1)

[F1]25% of the shares will vest and become exercisable on April 19, 2012, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

TRANZYME INC

CIK 0001274644

Entity typeother

Related Parties

1

filerCIK 0001515616

Filing Metadata

Form type: 4
Filed: Apr 20, 8:00 PM ET
Accepted: Apr 21, 6:18 PM ET
Size: 5.3 KB

View on SEC.gov